Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Infectious Diseases

• Publication date

  2011-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/infdis/jir180PMID 21606540PMCID PMC3100512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis B vaccination and risk of hepatitis B infection in HIV-infected individuals

  2010cited by this paper
• Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to Care

  2009cited by this paper
• Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count.

  2009cited by this paper
• Virologic and Immunologic Correlates With the Magnitude of Antibody Responses to the Hepatitis A Vaccine in HIV-Infected Children on Highly Active Antiretroviral Treatment

  2009cited by this paper
• Immunological Efficacy of a Three-Dose Schedule of Hepatitis A Vaccine in HIV-Infected Adults: HEPAVAC Study

  2008cited by this paper
• Predictors of immunity after hepatitis A vaccination in HIV‐infected persons

  2007cited by this paper
• BMC Infectious Diseases BioMed Central

  2007cited by this paper
• Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2006cited by this paper
• Response to hepatitis A vaccine in HIV‐positive patients 1

  2006cited by this paper
• Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.

  2006cited by this paper
• Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

  2006cited by this paper
• Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis.

  2006cited by this paper
• Response to hepatitis A vaccine in HIV patients in the HAART era

  2005cited by this paper
• Applied Longitudinal Analysis

  2005cited by this paper
• Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.

  2005cited by this paper
• Hepatitis A vaccine: Indirect evidence of immune memory 12 years after the primary course

  2004cited by this paper
• Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.

  2004influential reference
• HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.

  2004cited by this paper
• Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.

  2004cited by this paper
• Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial.

  2003cited by this paper
• Hepatitis A booster vaccination : Is there a need?

  2003cited by this paper
• Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection.

  2002cited by this paper
• Excellent Booster Response 4-6 y after a Single Primary Dose of an Inactivated Hepatitis A Vaccine

  2002cited by this paper
• Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA.

  2002cited by this paper
• Prolonged hepatitis A infection in an HIV‐1 seropositive patient

  2002cited by this paper
• Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.

  2001cited by this paper
• Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines.

  2001cited by this paper
• Occurrence of acute hepatitis A in patients infected with human immunodeficiency virus.

  2001cited by this paper
• Hepatitis A in patients with chronic liver disease – severity of illness and prevention with vaccination

  2000cited by this paper
• Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines.

  2000cited by this paper
• Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

  1999cited by this paper
• Statistical Models for Predicting the Duration of Vaccine-Induced Protection

  1999cited by this paper
• Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.

  1999cited by this paper
• Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

  1998cited by this paper
• Hepatitis A in human immunodeficiency virus-infected patients.

  1998cited by this paper
• Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

  1998cited by this paper
• Immune globulin and vaccine therapy to prevent hepatitis A infection.

  1998cited by this paper
• Response to hepatitis A vaccination in human immunodeficiency virus-infected and -uninfected homosexual men.

  1997cited by this paper
• Inactivated hepatitis A vaccine: long-term antibody persistence.

  1997cited by this paper
• Hepatitis A vaccine responses in HIV-positive persons with haemophilia.

  1996cited by this paper
• Safety and effectiveness of the new inactivated hepatitis A virus vaccine.

  1995cited by this paper
• Clinical experience with an inactivated hepatitis A vaccine.

  1995cited by this paper
• Immunogenicity and safety of an inactivated hepatitis a vaccine in anti‐HIV positive and negative homosexual men

  1995cited by this paper
• Protection against hepatitis A by an inactivated vaccine.

  1994cited by this paper
• Patterns of Immunogenicity of an Inactivated Hepatitis A Vaccine in Anti-HIV Positive and Negative Hemophilic Patients

  1994cited by this paper
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

  1993cited by this paper
• HEPATITIS A

  1977cited by this paper

• Long-term Immunogenicity of Hepatitis A Vaccination in Adults Receiving Immunosuppressive Therapy and Adults Living With HIV: Three-year Follow-up of a Prospective Cohort Study

  2025cites this paper
• Estrogen Modulation of B Cell Immunity: Implications for HIV Control and Therapeutic Strategies

  2025cites this paper
• Efficacy and Durability of Immune Response After Receipt of Hepatitis A Vaccine in People With Human Immunodeficiency Virus

  2025cites this paper
• Attenuation of hepatitis A antibody after immunization with hepatitis A vaccine (Aimmugen) in people living with HIV

  2024cites this paper
• Correlates of Breakthrough SARS-CoV-2 Infections in People with HIV: Results from the CIHR CTN 328 Study

  2024cites this paper
• Cost-effectiveness of expanded hepatitis A vaccination among adults with diagnosed HIV, United States

  2023cites this paper
• Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus

  2023cites this paper
• Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain.

  2023cites this paper
• Humoral immune response to two doses of COVID‐19 mRNA‐based vaccines in people living with HIV: A systematic review and meta‐analysis

  2023cites this paper
• A randomized clinical trial of one-dose versus accelerated two-dose schedule for hepatitis A virus revaccination among people with HIV who were non-responders or had seroreversion after primary HAV vaccination.

  2023cites this paper
• Acute Hepatitis A Viral Infection in People With HIV With Previously Documented Hepatitis A Immunity or Appropriate Vaccination: A Case Series

  2021cites this paper
• CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study

  2021cites this paper
• Hepatitis A vaccination and its immunological and epidemiological long-term effects – a review of the evidence

  2020cites this paper
• Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention.

  2020cites this paper
• Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020

  2020cites this paper
• Immune response to hepatitis A vaccine in patients with HIV.

  2019cites this paper
• Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors

  2019influential citation
• Notes from the Field: Acute Hepatitis A Virus Infection Among Previously Vaccinated Persons with HIV Infection — Tennessee, 2018

  2019cites this paper
• Vaccination in the Adult Patient Infected with HIV: A Review of Vaccine Efficacy and Immunogenicity.

  2019cites this paper
• T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders

  2018cites this paper
• Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV‐positive individuals whose anti‐HAV antibody waned after primary vaccination

  2018cites this paper
• Evidence for positive selection of hepatitis A virus antigenic variants in vaccinated men-having-sex-with men patients: Implications for immunization policies

  2018cites this paper
• 70 – Vaccination of Human Immunodeficiency Virus–Infected Persons

  2018cites this paper
• 24 – Hepatitis A Vaccines

  2018cites this paper
• Epidemiologia molecular dels brots de gastroenteritis per norovirus i d'hepatitits A: de la seqüència consens a la quasiespècie

  2018cites this paper
• Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II

  2017cites this paper
• Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review

  2017cites this paper
• Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I

  2017cites this paper
• Hepatitis A and E

  2017cites this paper
• Immunization of HIV-infected adult patients — French recommendations

  2016cites this paper
• CD4/CD8 Ratio Predicts Yellow Fever Vaccine-Induced Antibody Titers in Virologically Suppressed HIV-Infected Patients

  2016cites this paper
• British HIV Association Guidelines on the Use of Vaccines in HIV‐Positive Adults 2015

  2016cites this paper
• Vaccination des personnes vivant avec le VIH

  2016cites this paper
• Hepatitis B and A vaccination in HIV-infected adults: A review

  2015cites this paper
• Persistence of hepatitis A virus antibodies after primary immunization and response to revaccination in children and adolescents with perinatal HIV exposure

  2015cites this paper
• Response to Hepatitis A Vaccination in Immunocompromised Travelers.

  2015cites this paper
• Epidemiology of sexually transmitted viral hepatitis in human immunodeficiency virus-positive men who have sex with men in Asia.

  2015cites this paper
• Durability of response to vaccination against viral hepatitis A in HIV-infected patients: a 5-year observation

  2014cites this paper
• Long-term persistence of hepatitis A antibodies in pediatric HIV-infected patients after primary immunization: association with immunological profile and response to revaccination.

  2014cites this paper
• Prevalence and titre of antibodies against Hepatitis A virus in HIV-infected men having sex with men in Greece.

  2014cites this paper
• 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.

  2014cites this paper
• 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.

  2014cites this paper
• Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence.

  2014cites this paper
• Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates

  2014cites this paper
• Vaccination in HIV-Infected Adults

  2014cites this paper
• Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.

  2014cites this paper
• Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus–infected and ‐uninfected men who have sex with men

  2013cites this paper
• Factors associated with the immune response to hepatitis A vaccination in HIV-infected patients in the era of highly active antiretroviral therapy.

  2013cites this paper
• Hepatitis A Vaccination and Immunological Parameters in HIV-Infected Patients

  2013cites this paper
• The Burden of Liver Disease in Human Immunodeficiency Virus-Infected Patients

  2012cites this paper
• The immunosuppressed traveler.

  2012cites this paper
• Vaccination against viral hepatitis of HIV-1 infected patients

  2012cites this paper
• Long-term protective effects of hepatitis A vaccines. A systematic review.

  2012cites this paper
• Immune response to hepatitis a vaccination in HIV-infected men in Greece

  2012cites this paper
• Hepatitis A Virus among Drug Users and the Role of Vaccination: A Review

  2012influential citation
• Determinants of Hepatitis A Vaccine Immunity in a Cohort of Human Immunodeficiency Virus-Infected Children Living in Switzerland

  2012cites this paper
• Responses to hepatitis A virus vaccine in HIV-infected women: effect of hormonal contraceptives and HIV disease characteristics.

  2012cites this paper
• Advances in hepatitis immunization (A, B, E): public health policy and novel vaccine delivery

  2012cites this paper
• Hepatitis A vaccination among human immuno- deficiency virus (HIV)-infected adults: Current evidence and unanswered questions

  2012influential citation
• Clinical and laboratory characteristics of human immunodeficiency virus-infected adolescents: experience from a single medical center.

  2012cites this paper